YD Bio Ltd (YDES)Healthcare | Biotechnology | Taipei, Taiwan | NasdaqGM
5.44 USD
+0.14
(2.642%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 5.44 Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:03 a.m. EDT
Despite recent news of a Nasdaq listing and insider compensation, YD Bio (YDES) shows significant technical selling pressure in the last two weeks, dropping from 8.10 to 5.44. The short-term forecasting model predicts a 45-day downside of nearly 14%, while the stock remains severely overvalued relative to sales (P/S > 750) and shows no dividend potential or cash flow generation. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.355573 |
| AutoETS | 0.413261 |
| MSTL | 0.414859 |
| AutoARIMA | 0.416618 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 46% |
| H-stat | 6.33 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.733 |
| Excess Kurtosis | -0.56 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.338 |
| Revenue per Share | 0.466 |
| Market Cap | 383,636,192 |
| Beta | 0.22 |
| Profit Margins | -276.58% |
| Previous Name | Breeze Holdings Acquisition Corp. |
| Website | https://www.ydesgroup.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5928144 |
| Address1 | No. 3, Xingnan St. |
| Address2 | 12F. Nangang Dist. |
| All Time High | 25.0 |
| All Time Low | 5.12 |
| Ask | 7.0 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 29,410 |
| Average Daily Volume3 Month | 26,791 |
| Average Volume | 26,791 |
| Average Volume10Days | 29,410 |
| Beta | 0.221 |
| Bid | 5.05 |
| Bid Size | 1 |
| Book Value | 4.571 |
| City | Taipei |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.44 |
| Current Ratio | 13.183 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.05 |
| Day Low | 5.2 |
| Debt To Equity | 0.338 |
| Display Name | YD Bio |
| Ebitda | -1,357,195 |
| Ebitda Margins | -2.6592898 |
| Enterprise To Ebitda | -3.487 |
| Enterprise To Revenue | 9.274 |
| Enterprise Value | 4,733,174 |
| Eps Trailing Twelve Months | -0.02 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 7.82616 |
| Fifty Day Average Change | -2.38616 |
| Fifty Day Average Change Percent | -0.30489537 |
| Fifty Two Week Change Percent | -59.281437 |
| Fifty Two Week High | 25.0 |
| Fifty Two Week High Change | -19.56 |
| Fifty Two Week High Change Percent | -0.78239995 |
| Fifty Two Week Low | 5.12 |
| Fifty Two Week Low Change | 0.32000017 |
| Fifty Two Week Low Change Percent | 0.06250004 |
| Fifty Two Week Range | 5.12 - 25.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,756,215,000,000 |
| Float Shares | 321,096 |
| Free Cashflow | -3,875,569 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.3044 |
| Gross Profits | 155,356 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.81369 |
| Held Percent Institutions | 0.00471 |
| Implied Shares Outstanding | 70,521,359 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-08-29 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Long Business Summary | YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. |
| Long Name | YD Bio Ltd |
| Market | us_market |
| Market Cap | 383,636,192 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1898493574 |
| Most Recent Quarter | 1,735,603,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -1,411,559 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 383,636,192 |
| Open | 5.5 |
| Operating Cashflow | -1,836,818 |
| Operating Margins | -4.44588 |
| Payout Ratio | 0.0 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 5.44 |
| Post Market Time | 1,776,456,605 |
| Prev Name | Breeze Holdings Acquisition Corp. |
| Previous Close | 5.3 |
| Price Hint | 2 |
| Price To Book | 1.1901115 |
| Price To Sales Trailing12 Months | 751.6972 |
| Profit Margins | -2.76581 |
| Quick Ratio | 12.906 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.14 |
| Regular Market Change Percent | 2.64151 |
| Regular Market Day High | 6.05 |
| Regular Market Day Low | 5.2 |
| Regular Market Day Range | 5.2 - 6.05 |
| Regular Market Open | 5.5 |
| Regular Market Previous Close | 5.3 |
| Regular Market Price | 5.44 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 86,372 |
| Return On Assets | -0.25432 |
| Return On Equity | -0.42689 |
| Revenue Growth | 0.956 |
| Revenue Per Share | 0.466 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 70,521,359 |
| Shares Percent Shares Out | 0.0004 |
| Shares Short | 24,795 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 38,808 |
| Short Name | YD Bio Limited |
| Short Percent Of Float | 0.0018000001 |
| Short Ratio | 1.16 |
| Source Interval | 15 |
| Symbol | YDES |
| Total Cash | 3,132,298 |
| Total Cash Per Share | 2.173 |
| Total Debt | 22,265 |
| Total Revenue | 510,360 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.02 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.975648 |
| Two Hundred Day Average Change | -6.535648 |
| Two Hundred Day Average Change Percent | -0.54574484 |
| Type Disp | Equity |
| Volume | 86,372 |
| Website | https://www.ydesgroup.com |
| Zip | 115,001 |